https://scholars.lib.ntu.edu.tw/handle/123456789/566042
標題: | Preparation and evaluation of self-microemulsifying delivery system containing 5-demethyltangeretin on inhibiting xenograft tumor growth in mice | 作者: | Chou, Y.-C. Li, S. Ho, C.-T. Pan, M.-H. MIN-HSIUNG PAN |
關鍵字: | 5-Demethyltangeretin (5-DTAN); Colon cancer; Self-microemulsifying delivery system (SMEDS) | 公開日期: | 2020 | 卷: | 579 | 來源出版物: | International Journal of Pharmaceutics | 摘要: | 5-Demethyltangeretin (5-DTAN), a polymethoxylated flavone found in citrus peels, exhibits highly potent anti-cancer activity. However, 5-DTAN is a hydrophobic compound with poor aqueous solubility, which limits its oral bioavailability and efficacy. In this study, we aimed to develop and characterize an optimal self-microemulsifying delivery system (SMEDS) formulated for 5-DTAN and to assess its anticancer activity in a xenograft model. SMEDS is a lipid-based formulation and typically comprises oil, surfactant, and co-surfactant. The results from our solubility and compatibility test revealed that ethyl oleate and d-limonene were appropriate for use as an oil phases. The optimal formulation comprised ethyl oleate/d-limonene (10%/5%), Cremophor? EL (59.5%), and PEG 400 (25.5%). With this optimal formulation, the mean particle size was 97.1 ± 6.50 nm with the highest 5-DTAN loading (3.01 ± 0.38 mg/mL) determined by photon correlation spectroscopy. The transmission electron microscopy (TEM) morphology of 5-DTAN microemulsion droplets demonstrated a spherical shape and uniform size. Our findings suggest that using 5-DTAN loading SMEDS is an effective approach for inhibiting tumor growth in colon cancer xenograft mice. In summary, this study is the first to successfully demonstrate that oral administration of 5-DTAN-loaded SMEDS serves as a promising nutraceutical for cancer prevention. ? 2020 Elsevier B.V. |
URI: | https://www.scopus.com/inward/record.url?eid=2-s2.0-85079392221&partnerID=40&md5=e75bcb23cebc6cf13f788f2fd60bff24 https://scholars.lib.ntu.edu.tw/handle/123456789/566042 |
DOI: | 10.1016/j.ijpharm.2020.119134 | SDG/關鍵字: | 5 demethyltangeretin; antineoplastic agent; cremophor; limonene; oil; oleic acid ethyl ester; unclassified drug; antineoplastic agent; flavone derivative; gardenin B; oleic acid; surfactant; animal experiment; animal model; animal tissue; antineoplastic activity; Article; cancer inhibition; cancer prevention; controlled study; drug delivery system; drug formulation; drug solubility; human; human cell; loading drug dose; male; microemulsion; mouse; nonhuman; particle size; photon correlation spectroscopy; priority journal; transmission electron microscopy; tumor xenograft; animal; chemistry; colon tumor; drug screening; emulsion; HT-29 cell line; medicinal chemistry; oral drug administration; pathology; Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; Chemistry, Pharmaceutical; Colonic Neoplasms; Drug Delivery Systems; Emulsions; Flavones; HT29 Cells; Humans; Limonene; Male; Mice; Oleic Acids; Particle Size; Surface-Active Agents; Xenograft Model Antitumor Assays |
顯示於: | 食品科技研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。